Jadersten M, Boriskina K, Lindholm C, Westrom S, et al. Limited benefit in patients with MDS receiving venetoclax and azacitidine as a bridge to allogeneic stem cell transplantation. Leuk Lymphoma 2021 Nov 15:1-4. doi: 10.1080/10428194.2021.2002319.
PMID: 34775885